Illumina

Director, Global Market Access Strategy – Oncology (Remote)

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Healthcare, GenomicsIndustries

Director of Global Market Access Strategy – Oncology

Employment Type: Full time

Position Overview

At Illumina, we are advancing the future of cancer care by unlocking the power of the genome. As the Director of Global Market Access Strategy – Oncology, you will lead global strategies to ensure patients worldwide have access to our transformative oncology testing solutions. Spanning hereditary risk testing, solid and liquid tumor profiling and monitoring, your work will help shape the future of precision oncology. This includes Market Access strategies for emerging oncology testing applications and indications (e.g., WGS, MRD, and early detection).

This is a high-impact, strategic leadership role that requires deep expertise in oncology diagnostics, payer engagement, and global reimbursement landscapes. You will collaborate across regions and functions to shape the value narrative, secure reimbursement, and drive adoption of our technologies in diverse healthcare systems.

Key Responsibilities

  • Develop and global market access strategies for Illumina’s oncology diagnostic solutions, including comprehensive genomic profiling (CGP), liquid biopsy, and companion diagnostics, addressing unmet needs and evidence gaps. This includes both research kits and in vitro diagnostic Illumina products.
  • Partner with regional and country Teams to secure reimbursement and access in key markets, addressing diverse payer requirements and Health Technology Assessment processes. This includes participation in coalitions and industry groups to progress testing access.
  • Deeply collaborate with regional Government Affairs, Commercial, Medical Affairs, and Marketing Teams to align and execute strategies to gain, protect, and expand access to genomic solutions and emerging applications.
  • Define and communicate the clinical and economic value of diagnostics through compelling value propositions, evidence generation studies, and payer engagement.
  • Support and partner with the Global Health Economics and Outcomes Team on evidence generation strategies, including clinical utility studies, real-world evidence, and health economic and costing models tailored to oncology.
  • Monitor global policy trends, HTA requirements, and payer expectations related to oncology to inform strategic planning and product development.
  • Develop and update global value dossiers, reimbursement toolkits, and payer engagement materials to support local execution.
  • In collaboration with regional Market Access, build and maintain relationships with external stakeholders, including payers, HTA bodies, advocacy groups, and policy makers.
  • Maintain positive working relationships across key channels including customers, distributors, and core laboratories.
  • Support Commercial and Marketing in engagements including meetings, conferences, and symposiums.
  • Provide strategic input into product development, launch planning, customer channel considerations, and lifecycle management to align with access and commercialization goals. Provide guidance on realization of value of emerging Illumina technologies.
  • Lead Illumina product coding and pricing with appropriate regional and coverage segment bodies in collaboration with Product Management and other Illumina functions.
  • Ensure compliance with company, international regulatory, legal, and ethical standards.

Qualifications

  • Bachelor's Degree

About Illumina

What if the work you did every day could impact the lives of people you know? Or all of humanity? At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients. Working at Illumina means being being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world changing projects, you will do more and become more than you ever thought possible.

Company Information

  • Location Type: [Information not provided]
  • Salary: [Information not provided]

Skills

Global Market Access Strategy
Oncology Diagnostics
Payer Engagement
Reimbursement
Genomic Technology
Precision Oncology
Hereditary Risk Testing
Solid Tumor Profiling
Liquid Tumor Profiling
Companion Diagnostics
In Vitro Diagnostics

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI